JP2003501110A5 - - Google Patents

Download PDF

Info

Publication number
JP2003501110A5
JP2003501110A5 JP2001502873A JP2001502873A JP2003501110A5 JP 2003501110 A5 JP2003501110 A5 JP 2003501110A5 JP 2001502873 A JP2001502873 A JP 2001502873A JP 2001502873 A JP2001502873 A JP 2001502873A JP 2003501110 A5 JP2003501110 A5 JP 2003501110A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
vaccine
seq
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001502873A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003501110A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/015925 external-priority patent/WO2000076540A2/en
Publication of JP2003501110A publication Critical patent/JP2003501110A/ja
Publication of JP2003501110A5 publication Critical patent/JP2003501110A5/ja
Pending legal-status Critical Current

Links

JP2001502873A 1999-06-10 2000-06-09 肺炎連鎖球菌タンパク質とワクチン Pending JP2003501110A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13845399P 1999-06-10 1999-06-10
US60/138,453 1999-06-10
PCT/US2000/015925 WO2000076540A2 (en) 1999-06-10 2000-06-09 Streptococcus pneumoniae proteins and vaccines

Publications (2)

Publication Number Publication Date
JP2003501110A JP2003501110A (ja) 2003-01-14
JP2003501110A5 true JP2003501110A5 (enExample) 2007-08-16

Family

ID=22482080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001502873A Pending JP2003501110A (ja) 1999-06-10 2000-06-09 肺炎連鎖球菌タンパク質とワクチン

Country Status (9)

Country Link
EP (2) EP1731166B1 (enExample)
JP (1) JP2003501110A (enExample)
AT (2) ATE325620T1 (enExample)
AU (1) AU777856B2 (enExample)
CA (1) CA2371714C (enExample)
DE (2) DE60027890T2 (enExample)
ES (2) ES2264419T3 (enExample)
HK (1) HK1043943A1 (enExample)
WO (1) WO2000076540A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129340B1 (en) 1997-07-02 2006-10-31 sanofi pasteur limited/sanofi pasteur limitée Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
EP1456231A2 (en) 2001-12-20 2004-09-15 Shire Biochem Inc. Streptococcus antigens
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
BRPI0620460B8 (pt) 2005-12-22 2021-05-25 Glaxosmithkline Biologicals Sa uso de composição imunogênica para bebês, e, processo para produzir uma vacina
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
BRPI0813644B8 (pt) 2007-06-26 2021-05-25 Glaxosmithkline Biologicals Sa composição imunogênica, vacina, processo para fabricar a mesma, e, uso da composição imunogênica ou vacina
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
AU2008336295B2 (en) 2007-12-13 2013-07-11 Intervacc Ab Improved immunizing composition
ES2546213T3 (es) 2008-03-03 2015-09-21 Novartis Ag Compuestos y composiciones como moduladores de la actividad de TLR
US20120164178A1 (en) 2008-04-16 2012-06-28 Ballou Jr William Ripley Vaccine
CA2765112A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
CN107126557A (zh) 2009-06-29 2017-09-05 健诺西生物科学公司 抗肺炎链球菌的疫苗和组合物
AU2010290896B2 (en) 2009-09-02 2014-07-03 Glaxosmithkline Biologicals S.A. Immunogenic compositions including TLR activity modulators
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
WO2011030218A1 (en) 2009-09-10 2011-03-17 Novartis Ag Combination vaccines against respiratory tract diseases
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
US9408907B2 (en) 2009-12-15 2016-08-09 Glaxosmithkline Biologicals Sa Homogenous suspension of immunopotentiating compounds and uses thereof
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
AU2011232421B2 (en) 2010-03-23 2015-08-13 Novartis Ag Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
WO2012100234A1 (en) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
SG194733A1 (en) 2011-05-17 2013-12-30 Glaxosmithkline Biolog Sa Vaccine against streptococcus pneumoniae
CN104519910B (zh) 2012-03-07 2017-05-03 诺华股份有限公司 肺炎链球菌抗原的含佐剂制剂
TR201807340T4 (tr) 2013-02-01 2018-06-21 Glaxosmithkline Biologicals Sa Çan benzeri reseptör agonistleri içeren immünolojik kompozisyonların intradermal yoldan verilmesi.
GB201711635D0 (en) 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition
PL3752182T3 (pl) 2018-02-12 2024-11-25 Inimmune Corporation Ligandy receptorów toll-podobnych
CA3198876A1 (en) 2020-11-04 2022-05-12 Eligo Bioscience Cutibacterium acnes recombinant phages, method of production and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2271720A1 (en) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
WO2000006738A2 (en) * 1998-07-27 2000-02-10 Microbial Technics Limited NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)

Similar Documents

Publication Publication Date Title
CA2371714A1 (en) Streptococcus pneumoniae proteins and vaccines
JP2003515323A5 (enExample)
JP2006525330A5 (enExample)
RU2006127314A (ru) Вакцина, стимулирующая рост, основанная на нейтрализующем эпитопе
CN1610697A (zh) 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途
EP2292644A3 (en) Small Streptococcus pyogenes antigens and their use
CA2674837A1 (en) Anti-ige vaccines
CA2144307A1 (en) Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
JP2003530872A5 (enExample)
NO20011381L (no) Preparater av streptokokk C<beta>-protein
IL127595A0 (en) Polypeptides capable of forming antigen binding structures with specificity for the rhesus D antigens the DNA encoding them and the process for their preparation and use
JP2002534481A5 (enExample)
CA2249746A1 (en) Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
DK200601181A (da) Fiskevaccine
CA2967778A1 (en) Anti-thyroglobulin t cell receptors
IL125645A0 (en) Recombinant phages
CA2411919A1 (en) Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
CA2475821A1 (en) Group b streptococcus antigens
CA2338886A1 (en) Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
CA2353802A1 (en) New protective antigen of group a streptococci
JP2005535287A5 (enExample)
KR20010081018A (ko) 항원 유전자 서열의 동정 방법
JP2004502782A5 (enExample)
CA2411927A1 (en) Immunization of dairy cattle with gapc protein against streptococcus infection
JP2004531235A5 (enExample)